Procurement Summary
Country: Brazil
Summary: Intention to Register Prices for Future and Possible Acquisition of Ceaf Medicines (Miscellaneous) - Intention Rp 079/2025 (For all Items, the Descriptions Available on Compras Net Differ from the T...
Deadline: 09 Jun 2026
Posting Date: 19 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 141593422
Document Ref. No.: 91244/2025
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Object: Electronic Auction - Intention to Register Prices for future and possible ACQUISITION OF CEAF MEDICINES (MISCELLANEOUS) - INTENTION RP 079/2025 (FOR ALL ITEMS, THE DESCRIPTIONS AVAILABLE ON COMPRAS NET DIFFER FROM THE TERMS OF REFERENCE, CONSIDER FOR PRESENTATION OF ITEMS THE TERMS OF REFERENCE OF THIS CERTIFICATE, AS PUBLICATION ON THE NOTICE BOARD). UASG code: 925998 Notice from: 05/19/2026 from 08:00 to 14:00 Proposal Delivery: from 05/19/2026 at 08:00 BEZAFIBRATE, DOSAGE 200 MG Quantity: 936 CLOBAZAM, DOSAGE 20 MG Quantity: 16848 SODIUM PAMIDRONATE, CONCENTRATION 60 MG, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION Quantity: 10 PRAVASTATINE, DOSAGE 20 MG Quantity: 28080 PRAVASTATINE, DOSAGE 40MG Quantity: 14040 INTERFERON, COMPOSITION ALPHA 2B, CONCENTRATION 10, 000, 000 IU, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION Quantity: 332 INTERFERON, COMPOSITION ALPHA 2B, CONCENTRATION 10, 000, 000 IU, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION Quantity: 110 INTERFERON, COMPOSITION ALPHA 2B, CONCENTRATION 3, 000, 000 IU, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION Quantity: 1092 INTERFERON, COMPOSITION ALPHA 2B, CONCENTRATION 3, 000, 000 IU, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION Quantity: 364 INTERFERON, ALPHA 2B COMPOSITION, CONCENTRATION 5, 000, 000 IU, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION Quantity: 663 INTERFERON, COMPOSITION ALPHA 2B, CONCENTRATION 5, 000, 000 IU, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION Quantity: 221 OCTREOTIDE, ACETATE SALT COMPOSITION, CONCENTRATION 10 MG, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION, ADDITIONAL CHARACTERISTICS WITH APPLICATION SYSTEM Quantity: 165 OCTREOTIDE, COMPOSITION ACETATE SALT, CONCENTRATION 10 MG, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION, ADDITIONAL CHARACTERISTICS WITH SYSTEM APPLICATION Quantity: 22 SAPROPTERIN DICHHLORHYDRATE, CONCENTRATION 100 MG, FOR...
Documents
Tender Notice